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Abstract
Amelogenesis imperfecta (AI) is a heterogeneous group of genetic conditions that result in defective dental enamel
formation. Amelotin (AMTN) is a secreted protein thought to act as a promoter of matrix mineralization in the final stage of
enamel development, and is strongly expressed, almost exclusively, in maturation stage ameloblasts. Amtn overexpression
and Amtn knockout mouse models have defective enamel with no other associated phenotypes, highlighting AMTN as an
excellent candidate gene for human AI. However, no AMTN mutations have yet been associated with human AI. Using whole
exome sequencing, we identified an 8,678 bp heterozygous genomic deletion encompassing exons 3-6 of AMTN in a Costa
Rican family segregating dominant hypomineralised AI. The deletion corresponds to an in-frame deletion of 92 amino acids,
shortening the protein from 209 to 117 residues. Exfoliated primary teeth from an affected family member had enamel that
was of a lower mineral density compared to control enamel and exhibited structural defects at least some of which appeared
to be associated with organic material as evidenced using elemental analysis. This study demonstrates for the first time that
AMTN mutations cause non-syndromic human AI and explores the human phenotype, comparing it with that of mice with
disrupted Amtn function.
Introduction
Amelogenesis is the formation of dental enamel, which con-
sists predominantly of hydroxyapatite (HA) crystals (1). The
process has three contiguous developmental stages that ulti-
mately result in the most highly mineralised mammalian tis-
sue, with distinctive structure, high mechanical strength and
the ability to maintain function over a lifetime without cellular
repair.
During the secretory stage, a proteinaceous extracellular
matrix is incrementally laid-down by epithelially-derived ame-
loblasts via specialised cellular extensions termed Tomes’
processes. This matrix partially mineralises to delineate the
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enamel architecture which is characterised by bundles of
enamel crystals (enamel prisms or rods) interdigited with inter-
prismatic enamel crystals (2). As the enamel layer approaches
full thickness, the Tomes’ process is retracted and the final
outer enamel layer is aprismatic. The ameloblasts then enter
the transition stage, characterised by reduced matrix protein se-
cretion and internal reorganization (3). The cells then enter the
maturation stage and begin secreting the serine protease KLK4
that completely degrades the proteinaceous matrix, leaving the
immature enamel crystals bathed in enamel tissue fluid (4).
Concomitantly, maturation stage cells cycle between so called
rough and smooth ended ameloblasts; the former associated
with acidification of the enamel microenvironment and mas-
sive active transport of mineral ions into the enamel and the
latter associated with alkalination of the enamel microenviron-
ment and protein readsorption (5). The significant increase in
the active transport of mineral ions into the matrix during this
stage accelerates enamel crystal growth in both width and
thickness until the tissue volume is eventually occluded by
mineral (6). Finally, the ameloblasts reduce, undergo apoptosis
and on tooth eruption, are completely lost (7).
Amelogenesis imperfecta (AI) (MIM 104530) is a group of ge-
netic conditions that result from defective amelogenesis. The
enamel produced can be hypoplastic or hypomineralised due to
inadequate enamel volume or mineralization, respectively.
Mixed phenotypes also occur. The prevalence of AI is reported
to be between 1/700 and 1/14,000 depending upon the popula-
tion studied (8,9). The effect of AI on patients’ well-being is pro-
found and the clinical care required is both challenging and
costly (10).
AI may present in isolation or may be a component of syn-
dromic disease. Autosomal recessive, dominant and X-linked
forms of non-syndromic AI are recognised and mutations in
many genes have already been shown to be causative (11–25). In
addition to the known genes, there are a number of strong can-
didate genes implicated in AI based on their known function,
pattern of expression and/or animal model studies. Foremost
among these is the gene encoding amelotin (AMTN:
MIM*610912) (26).
Amtn was first cloned in rodents during studies to identify
proteins secreted by the enamel organ (26,27). It is found within
a conserved enamel gene cluster located on chromosome 5 in
mice, chromosome 14 in rats and chromosome 4 in humans.
The cluster also includes the genes encoding enamelin
(MIM*606585) and ameloblastin (MIM*601259), mutations in
which are already known to cause AI (14,25). Amen encodes a
209 amino-acid protein rich in proline, leucine, threonine, gluta-
mine, and glycine, with an N-terminal signal sequence that,
once cleaved, gives rise to a mature 20.4 kDa secreted protein
(27,28). AMTN has been shown to be restricted to the basal lam-
ina of maturation stage ameloblasts, the structure that links
ameloblasts with the developing enamel (29). A functional study
by Abbarin and colleagues suggested that AMTN promotes HA
precipitation, serving a critical role in the formation of the final
compact aprismatic enamel surface layer during the maturation
stage of amelogenesis (30).
Consistent with these findings, both an Amtn overexpression
mouse model in which AMTN was over-expressed under the
control of an Amel promoter (pAmel:Amtnþ/þ), and a knockout
(Amtn-/-) mouse model, have defective enamel (31,32). The
pAmel:Amtnþ/þmouse model has brittle enamel that is thinner
than wild-type (WT), with a defective surface layer (31). By con-
trast the Amtn-/- mouse model has mandibular incisors with a
chalky appearance and rough, irregular surface enamel that is
easily chipped away, though maxillary incisors and molars
were unaffected, as were Amtnþ/- mice (32).
These observations have made AMTN a strong candidate
gene for involvement in human AI, as noted by a number of re-
search groups (30,33,34). To date, however, no human muta-
tions have been reported. Here we report the first human AMTN
mutation and show that the corresponding human phenotype
is non-syndromic dominant hypomineralised AI.
Results
Patient phenotype
We identified a Costa Rican family segregating autosomal domi-
nant hypomineralised AI in the absence of any co-segregating
health problems (Fig. 1 and Supplementary Material, Fig. S2).
Whole-exome sequencing
In order to identify the cause of AI in this family, we performed
whole exome sequencing (WES) on DNA from individuals II:2,
II:3, III:3 and IV:1. Following alignment, processing and dupli-
cate removal, a mean depth of 60.06, 89.77, 66.44 and 110.54
reads per base were observed, respectively for individuals II:2,
II:3, III:3 and IV:1 with 98.9%, 99.6%, 98.7% and 99.8% of the bases
covered by at least 5 reads respectively (further alignment sta-
tistics are available in Supplementary Material, Table S1). Indel
and single nucleotide variants were called in variant call format
(VCF) using the Haplotype Caller function of the Genome
Analysis Toolkit (GATK) (35).
In light of the autosomal dominant inheritance in the family
(confirmed by male-to-male transmission) and relative rarity of
AI, variants present in the National Centre for Biotechnology
Information’s dbSNP142 (dbSNP142; http://www.ncbi.nlm.nih.
gov/projects/SNP/), the National Heart, Lung and Blood
Institute’s Exome Sequencing Project’s Exome Variant Server
(EVS; http://evs.gs.washington.edu/EVS/) or the Exome
Aggregation Consortium v0.3 (ExAC; http://exac.broadinstitute.
org/) with minor allele frequencies equal to or greater than 0.1%
were excluded, as were homozygous variants and those located
on the X chromosome. The resulting variants were then filtered
to select those present in all three affected individuals (II:2, III:3
and IV:1) but not in the unaffected individual (II:3). This list was
further filtered to exclude all changes other than missense,
frameshift or stop mutations, exonic insertions/deletions or
variants located at splice consensus sites. This left a total of 26
variants with a Combined Annotation Dependent Depletion
(CADD) pathogenicity score (v1.3) of over 15 (Supplementary
Material, Table S2). Alongside variant calling, Copy Number
Variant (CNV) analysis was also performed, using ExomeDepth
software (36). This compares read depths across all captured
exons of samples from affected individuals (II:2, III:3 and IV:1)
and the unaffected individual (II:3) against the read depths of
between 5 to 10 samples from unrelated individuals whose DNA
had been processed within the same WES batches, using identi-
cal conditions, as the affected samples from the family.
None of the 26 potentially pathogenic variants identified
were in genes known to be involved in AI or implicated in AI
by function, expression or animal model studies. However, a
heterozygous deletion spanning exons 3 to 6 of AMTN
(chr4:71388473-71394475, GRCh37) was detected by the CNV
analysis software (Supplementary Material, Table S3 and Fig. S1).
While large CNVs are not reported in variant databases such as
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dbSNP and ExAC, this deletion was not present in the Database
of Genomic Variants (37).
PCR and Sanger sequencing
In order to investigate the potential heterozygous deletion further,
a long range PCR assay was undertaken using primers designed to
amplify introns 2 to 6 (Supplementary Material, Table S4). For WT
DNA, the product size was predicted to be 9,073 bp, but in affected
individuals only a product of approximately 400 bp was observed.
The large predicted WT band was never observed in controls nor
in patients, probably due to its large size. In contrast, PCR amplifi-
cation using primers flanking exons 6 and 7 produced a band of
the expected size (713 bp) in all individuals (Fig. 2A).
Sequencing of the introns 2 to 6 product from affected indi-
viduals confirmed the presence of a heterozygous deletion
within AMTN spanning a total of 8,678 bp, accompanied by a
4 bp insertion (chr4:71,385,896-71,394,573delinsCTCA; GRCh37).
The deletion encompasses all of the 276 bp of exons 3-6 plus
2,576 bp of 50 genomic sequence and 98 bp of 30 sequence
(c.54þ 1347_330þ 98delinsCTCA (NM_212557, Fig. 2B)). The het-
erozygous deletion was present in all available affected family
members (II:2, III:3 and IV:1) and absent from all unaffected
family members tested (II:3 and IV:2). This deletion is predicted
to create an in-frame deletion of 92 amino acids
(p.Q19_Q110del, NP_997722), shortening the protein from 209 to
117 amino acids (Fig. 2C).
In an attempt to determine the consequences of loss of
exons 3-6 on transcription of AMTN mRNA, leukocyte cDNA was
obtained from an affected individual (III:3). While cDNA amplifi-
cation with control primers (P53) was successful (data not
shown), amplification of AMTN products failed in both patient
and control cDNA. This is consistent with the reported tissue
specific expression pattern of Amtn, (26). As a consequence,
there is no detectable expression of AMTN mRNA in blood, a
known issue for enamel specific transcripts (25).
Based on this result, we screened all coding exons and flank-
ing introns of AMTN in an additional 35 dominant AI samples,
but no single nucleotide variants or small indels were identified
(Supplementary Material, Table S5). We also screened the co-
hort for the deletion identified in the family presented here, us-
ing the primer pair designed to amplify introns 2 to 6, but did
not identify any further families that carried the same deletion.
Enamel phenotyping
On clinical examination of the teeth, the three family members
heterozygous for the mutation (II:2, III:3 and IV:1) exhibited
hypomineralised AI (Fig. 1). Individuals II:3 and IV:2 did not
carry the mutation and exhibited a normal dentition
(Supplementary Material, Fig. S2).
Two deciduous teeth from IV:1 were available for phenotypic
characterization after natural exfoliation. High resolution-
computerised tomography (CT) scanning (Fig. 3 and supplemen-
tal videos 1-4) of control teeth 1 and 2 and teeth 3 and 4 from IV:I,
showed that teeth 3 and 4 exhibited reduced enamel mineral
density. The region of tooth 4 that had undergone restoration
was excluded from the analysis. Enamel thickness also appeared
to be reduced though this was difficult to confirm due to the pos-
sibility of post-eruptive tissue loss. The enamel mineral densities
of teeth 3 and 4 were 2.05 g/cm3þ/-0.02 g/cm3 (2x standard error
of the mean) and 2.16 g/cm3þ/-0.02 g/cm3 respectively, compared
to 2.66 g/cm3þ/-0.02 g/cm3 and 2.72þ/-0.06 g/cm3 for the two con-
trol teeth, 1 and 2. For reference, a range of 2.69-2.92 g/cm3 has
been previously reported for deciduous enamel (38).
On scanning electron microscopy (SEM), control tooth 1
(Fig. 4A and B) exhibited prismatic structure characteristic of
normal human enamel. Tooth 4 from individual IV:1 also ex-
hibited areas of prismatic enamel though the fine detail of the
ultrastructure was obscured by what appeared to be overlying
material (Fig. 4C and D). The enamel also displayed distinct re-
gions where the enamel structure was particularly disturbed;
Figure 1. Family pedigree and dental phenotype. (A) Pedigree of the Costa Rican family investigated. Affected family members are shaded. (B) The mixed dentition of
the index case, IV:1, aged 5 years (arrow on pedigree) was characterised by generalised hypomineralised AI with some hypoplasia involving all teeth. There was post-
eruptive enamel loss with retention of a thin band of enamel at the cervical margin (examples marked with *). Periodontal health was consistent with that expected for
patient age in each of the affected individuals with nothing to suggest a co-segregating phenotype.
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the prismatic structure having a “gnarled” appearance (Fig. 4E
and F). These regions spanned the entire enamel and were not
confined to the outermost enamel layers. In some areas of the
tooth, the enamel was missing, perhaps indicative of post erup-
tive failure under masticatory stress.
In order to determine whether the material that appeared to
be overlying the enamel of tooth 4 from individual IV:1 was of
organic origin, we treated the tooth with 6% sodium hypochlo-
rite which is well known for its ability to solubilise (oxidise) a
range of organic materials such as proteins, lipids and nucleic
acids. Overlying material was still obvious in the SEM and there-
fore apparently resistant to hypochlorite treatment
(Supplementary Material, Fig. S3).
Elemental analysis by energy dispersive X-ray spectroscopy
(EDX; Supplementary Material, Table S6 and Fig. S4), carried out
prior to the hypochlorite treatment, showed that control tooth 1
consisted primarily of elements expected to be found in enamel,
which is predominantly comprised of a substituted calcium hy-
droxyapatite (1,39). Atomic mass percentage contributions
showed that control tooth A enamel consisted of 57.2% oxygen,
19.9% calcium, 12.3% carbon and 10.1% phosphorus, with the re-
maining 0.45% being sodium. In contrast, tooth 4 enamel (indi-
vidual IV:1) showed varying elemental content depending upon
the area of enamel analysed. All areas of tooth 4 had higher car-
bon and lower oxygen percentage content than control tooth 1.
Three of the four enamel areas analysed for tooth 4 also had a
lower phosphorus percentage content than control tooth 1.
Furthermore, three areas of tooth 4 enamel contained nitrogen
(Area 1: 11.1%, area 2: 11.6% and area 4: 7.2%) which was not pre-
sent in enamel from control tooth 1.
EDX elemental analysis of tooth 4 enamel (individual IV:1)
following hypochlorite treatment (Supplementary Material,
Figure 2. Genotyping of the mutation, identification of the deletion breakpoints and a schematic diagram of the predicted effect of the deletion on the AMTN protein.
(A) PCR analysis of the heterozygous deletion of exons 3 to 6 of AMTN in the members of the family investigated. Amplification using primers spanning introns 3 to 6,
designed to produce a product of 9,073 bp for the wild-type allele, produced a product of 399 bp in affected individuals confirming a deletion encompassing exons 3 to
6. Amplification of exons 6 to 7 was observed in all individuals. (B) Sanger sequencing electropherograms of mutant and wild-type alleles to identify the deletion break-
points. Comparison of the mutant sequence with a control sequence revealed a deletion of 8,678 bp spanning exons 3 to 6 of AMTN and an insertion of 4 bp. (C)
Schematic diagrams of the wild-type and the predicted mutant AMTN protein structures. The predicted mutant AMTN protein lacks the amino acid sequence encoded
by exons 3 to 6, resulting in the loss of 92 amino acids. The contribution of each exon to the protein is signified by the boxes labelled with the number corresponding to
the exon number. Important motifs are labelled with symbols as follows: the line shows the position of the putative signal peptide, encoded by exon 2, the asterisk
shows the position of the LPQ motif, encoded by exons 2 and 3, the diamond shows the position of the IPLT motif, encoded by exon 4, predicted to be an O-glycosyla-
tion site. The arrow shows the position of the SXE phosphorylation motif, encoded by exon 7.
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Table S7 and Fig. S5) showed that the atomic mass percentages
of nitrogen and carbon were apparently reduced. This suggests
that some organic material may have been removed by the hy-
pochlorite treatment but the continued presence of an overlying
layer suggests that the material is comprised, in part at least, of
material that is resistant to hypochlorite.
Discussion
We identified a family from Costa Rica segregating autosomal
dominant hypomineralised AI. WES analysis of rare variants
and CNVs in known and candidate AI genes revealed a reduc-
tion in the number of reads across AMTN exons 3 to 6. Further
investigation confirmed this to be an 8,678 bp deletion encom-
passing exons 3-6 and flanking intronic sequence. PCR analysis
showed that the deletion segregates with the disease phenotype
in all available family members. A screen of 35 additional domi-
nant AI families revealed no further mutations.
AMTN consists of nine exons, of which eight (exons 2 to 9)
are protein coding. No transcript could be amplified from pa-
tient blood, so it was not possible to determine the precise effect
of the loss of exons 3-6 on the mRNA produced. One hypothesis
is that the deletion leads to the production of a mature tran-
script containing exons 1, 2, 7, 8 and 9. This is a strong possibil-
ity as the relevant splice consensus sequences remain intact
and the exons flanking those deleted are in phase zero, mean-
ing that the deletion would leave any translated protein in
frame (40). For this reason the transcript is unlikely to be subject
to nonsense-mediated decay (41).
Previous studies have found that AMTN exon 2 encodes the
putative signal peptide and exon 7 encodes a consensus SXE
phosphorylation motif targeted by the casein kinase FAM20C
Figure 3. High resolution X-ray CT analysis of exfoliated teeth from control individual and individual IV:1. Typical CT sections through the teeth are presented using
false colour calibrated with respect to mineral density to generate mineral density maps. Mean enamel mineral density for each tooth is also shown graphically, error
bars represent the twice the standard error of the mean. The teeth from the control individuals (Teeth 1 and 2) exhibit an enamel layer apparently normal in structure
and density. Teeth 3 and 4 from IV:1 exhibit an obvious enamel covering though it is thinner, chipped, absent in places and is reduced in mineral density compared
with teeth 1 and 2. Note that tooth 4 has undergone restoration (indicated by arrows). Videos of 3D rendered CT data showing surface detail and internal structure of
teeth 1-4 are available as Supplementary Material.
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(Family With Sequence Similarity 20, Member C, MIM*611061)
(27,34). Assuming that a mutant transcript and protein are pro-
duced, the deletion identified in the family described here
would not remove either of these highly conserved regions (34).
However, deletion of exons 3-6 would disrupt a conserved,
amino terminal, IPV like, tripeptide motif, LPQ, encoded by the
last six bases of exon 2 and the first three bases of exon 3 re-
spectively. This motif is thought to be responsible for the effi-
cient trafficking of acidic proteins (the calculated pI of
unmodified human AMTN is 5.29) out of the endoplasmic retic-
ulum (ER) (42). Mutations affecting the IPV motif of the dentin
matrix protein, dentin sialophosphoprotein (MIM *125485), are
known to result in dominant negative dentinogenesis imper-
fecta type I (MIM #125490) due to a failure to traffic the protein
out of the ER and the associated retention of WT protein (43).
The deletion identified in this family, if expressed, will replace
the polar glutamine residue encoded by the first three bases of
exon 3 with non polar glycine encoded by the first three ba-
ses of exon 7. The deletion would also delete an IPLT motif
in exon 4 (34), which is predicted to be an O-glycosylation
site and is therefore likely to be important for AMTN function
(44). Moreover, the deletion of a significant proportion of a pro-
tein or defective covalent modification may cause misfolding
leading to ER stress driven cell pathologies. Rat Amtn transcript
variants lacking exons 3 to 7 have been identified (27) suggest-
ing that amelotin lacking the IPV-like tripeptide motif and the
O-glycosylation site may still have some functional role and
that the protein is tolerated during secretory trafficking.
However, the expression level of this truncated Amtn transcript
is unknown and it may be that it is expressed at very low levels
only.
Pseudogenization of AMTN in enamel-less species has
meant that AMTN is regarded as an enamel-specific protein
(34). It has been proposed that prismatic enamel evolved in
mammals concurrently with AMTN expression becoming re-
stricted to the maturation stage and with changes to AMTN
exon boundaries and splicing (34,45,46). The exact function of
AMTN in mammals remains unknown, but its expression
within the basal lamina of maturation stage ameloblasts and at
the internal basal lamina within the junctional epithelium of
erupted rodent teeth suggests functions in both enamel miner-
alization and in dento-gingival attachment (26,27). However,
dento-gingival attachment appeared unaffected in both amelo-
tin null (Amtn-/-) mice (32) and AI affected individuals carrying
the heterozygous AMTN exon 3-6 deletion reported here.
In Amtn-/- mice (32,47), the effect on enamel phenotype var-
ied depending on tooth type, with the continually erupting
mandibular incisors most affected while molars appeared unaf-
fected and maxillary incisors were merely stained. These differ-
ences may be related to the rate of formation/eruption of the
different teeth; mandibular incisor enamel has less time in
which to fully mineralise prior to eruption and AMTN may be
required to ensure that the finished enamel surface is fully min-
eralised prior to enamel eruption. Enamel thickness (at erup-
tion) and the characteristic decussating prismatic architecture
were also apparently unaffected in Amtn-/- teeth, perhaps re-
flecting the fact that AMTN is not expressed during the secre-
tory stage in WT animals (enamel thickness and rod
architecture being determined during the secretory stage (48)).
In the ensuing transition/maturation stages, where AMTN is
maximally expressed and the enamel accrues the majority of its
final mineral content, secondary mineralization was delayed;
Figure 4. SEM of representative exfoliated teeth. (A and B) SEM of tooth 1 from the control individual, (C–F) SEM of tooth 4 from individual IV:1, boxed regions on pic-
tures A, C and E reflect the boundaries of the photographs taken at higher power in these regions, labelled B, D and F. Control tooth 1 exhibits normal, typical enamel
architecture comprising prisms (rods) of individual enamel crystallites. Tooth 4 exhibits both regions of relatively normal enamel and disturbed structure. The cross
sectional surface of Tooth 4 has a “smooth” appearance that may reflect the presence of organic material.
3583Human Molecular Genetics, 2016, Vol. 25, No. 16 |
especially in the deeper enamel layers (32,47). Our findings on
teeth from a patient heterozygous for the AMTN deletion
showed a 18.8–24.6% reduction in enamel mineral density com-
pared to control teeth, in contrast, the final mean enamel min-
eral density achieved across the full enamel thickness in Amtn-/-
teeth was reduced by 2.1% and was not significantly different to
WT (32,47). Microhardness values for the inner and middle
enamel layers in null mice were also no different to WT but the
microhardness of the surface layer in null mice was signifi-
cantly reduced by approximately 23% (47). It was concluded that
AMTN plays a crucial role in the production of a normally min-
eralised enamel surface in rodent mandibular incisors.
Unfortunately, given that the human teeth characterised in this
study were erupted and subject to wear in the mouth, it is not
possible to comment specifically on the integrity or otherwise of
the outer aprismatic enamel in the presence of this human
AMTN mutation.
Elemental analysis of one of the teeth from a human patient
carrying the AMTN mutation revealed consistently higher car-
bon and lower oxygen percentage content than control teeth.
Also, nitrogen was present in three out of four regions analysed
for the teeth from the human patient carrying the AMTN muta-
tion but was undetected in the control tooth. These data sug-
gested that organic material was present within the enamel and
are consistent with the SEM appearance of the affected teeth
which showed the presence of a layer of material obscuring
the underlying fine structure of the enamel architecture.
Hypochlorite treatment was used in an attempt to determine
the nature of this overlying material but SEM revealed no obvi-
ous change in the appearance of the enamel, or the material,
following treatment. However, analysis by EDX showed a reduc-
tion in the nitrogen and carbon content after treating the
enamel with hypochlorite, suggesting that at least some of the
organic material had been removed. We therefore conclude that
the remainder was refractory to hypochlorite treatment, per-
haps due to crosslinking or stabilization by interaction (or inclu-
sion) with an inorganic calcium phosphate phase.
Unusually high levels of organic material of developmental
origin have been previously reported to be present in hypoma-
turation forms of AI (49). Organic material of external origin (e.g.
salivary protein and protein from dietary sources) have been de-
tected in carious enamel (50) suggesting that disruption of the
enamel surface may allow organic material to enter the enamel
layer. In the affected tooth here, the organic material was not
confined to the surface layers but was present throughout the
enamel. However, we are unable to conclude whether the or-
ganic material detected entered the tissue post-eruption due to
disturbances in the enamel structure or whether it is of devel-
opmental origin, representing retained matrix protein.
The fact that the reduction in mean enamel mineral density
in the teeth of the human AI patient heterozygous for an AMTN
deletion was much greater than that in Amtn-/- mice, represents
a clear phenotypic difference between the mouse model and
the human phenotype characterised in this study. This may re-
flect the type of mutation present, since the human patients
have an in frame deletion, predicted to produce a mutant tran-
script and possibly also a mutant protein whereas the mice
have been shown not to produce any protein and to exhibit a
300 fold reduction in transcript levels (32). Nu~nez et al. reported
that heterozygous Amtnþ/- mice had no enamel defects and sug-
gested that murine amelogenesis is unaffected even in the pres-
ence of half of the normal amount of amelotin (47). This
suggests that the AMTN deletion identified here may have a
dominant-negative (toxic gain of function) effect due to the
presence of a mutated protein, rather than acting through
haploinsufficiency.
Whether any toxic gain of function, associated with the
8,678 bp heterozygous genomic deletion reported here is mani-
fest in the extracellular or intracellular compartments (or both)
is unclear. Amelotin has been shown to interact with itself and
with ODAM, leading to the hypothesis that it forms large aggre-
gates that are integral to the structure and function of the basal
lamina-like layer between the maturation stage ameloblasts
and the enamel surface (51–53). In the present study, the whole
enamel thickness is hypomineralized, suggesting that the mu-
tant AMTN may: (i) Disrupt the normal function of the basal
lamina-like layer compromising mineral ion ingress into the
deeper enamel; and/or (ii) Impede the egress of degraded
enamel matrix components out of the enamel impacting on the
mineralization of the whole enamel layer (the “smooth” appear-
ance of affected enamel seen in Figure 4C and D suggests the
presence of organic material overlying the crystals and the
nitrogen identified in EDX elemental analysis (Supplementary
Material, Table S6 and Fig. S4) that was partially extractable
using hypochlorite (Supplementary Material, Table S7 and Fig.
S5) also supports this) and/or (iii) mis-fold, impairing trafficking
through the ER, impacting directly on ameloblast function or
causing cell death through ER stress in a manner similar to that
described for a Y64H amelogenin mutation (54).
Given the long-standing status of AMTN as an AI candidate
gene, it may seem surprising that mutations have not been re-
ported previously. It is possible that in WES based studies, the
type of mutation identified here may have been overlooked due
to the bias inherent in this approach, which detects single nu-
cleotide variants and smaller indels much more effectively than
large indels or rearrangements. CNV analysis should therefore
be performed on WES data as a standard approach alongside
single/multiple nucleotide variant calling. Furthermore, the
large exonic deletion reported here is also unusual in that it
leaves the protein in the frame. It is possible that the majority
of heterozygous AMTN mutations in human patients do not re-
sult in a toxic gain of function, but rather are functional AMTN
knockouts, causing either no effect or a clinical phenotype so
mild that they remain undiagnosed.
In summary, identification of a 8,678 bp heterozygous geno-
mic deletion encompassing exons 3-6 of AMTN in a Costa Rican
family confirms for the first time that AMTN mutations can
cause autosomal dominant hypomineralized human AI in the
absence of other obvious co-segregating clinical features. The
mechanisms causing AI in this case are unclear, but the com-
parison between the enamel phenotype of exfoliated deciduous
teeth from human patients with that of Amtn-/- and Amtnþ/-
mouse models suggests that the mouse models do not accu-
rately reflect or predict the disease mechanism operating in this
human case. Rather, toxic gain of function, associated with the
mutant protein may drive pathology in these patients.
Materials and Methods
Patients
Affected individuals and family members were recruited follow-
ing informed consent in accordance with the principles outlined
by the declaration of Helsinki, with local ethical approval.
Genomic DNA samples were obtained using OrageneVR DNA
sample collection kits (DNA Genotek, ONT, Canada) according
to the manufacturer’s instructions.
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Whole exome sequencing and analysis
Three micrograms of genomic DNA were processed according to
the Agilent SureSelect XT Library Prep protocol (Agilent
Technologies, CA, US). Sure Select Human All Exon V5 (Agilent
Technologies) was used as the capture reagent. Sequencing was
performed using a 100 bp paired-end protocol on an Illumina
HiSeq 2500 sequencer (Illumina, CA, USA). The resulting fastq
files were aligned to the human reference genome (GRCh37) us-
ing Novalign software and processed in the SAM/BAM format
using Picard (http://picard.sourceforge.net) and the GATK java
programs (35). Exome depth was used for CNV analysis accord-
ing to the developers’ guidelines (36).
All genomic coordinates are based on the GRCh37 human
reference genome. The reference gene sequence upon which
AMTN mutation nomenclature is based is RefSeq transcript
NM_212557.
The variant identified in this study has been submitted to
the Leiden Open Variant Database at http://dna2.leeds.ac.uk/
LOVD/variant ID: 0000000172.
Tooth phenotyping
Two deciduous teeth were available after natural exfoliation for
phenotypic characterization. These were compared to two con-
trol teeth obtained from the Skeletal Tissues Research Bank
(School of Dentistry, University of Leeds) with ethical approval
and patient consent. The teeth were subjected to high resolu-
tion CT using a Skyscan 1172 (Brucker, UK) operated at 100 kV;
source current of 100 mA, using an Al/Cu filter to reduce beam
hardening. CT slices were reconstructed using Skyscan Recon
software and rendered as 3D videos using Skyscan CTVox soft-
ware. The CT images were calibrated using a calibration phan-
tom comprising of three different HA standard of known
mineral densities. Measurement of mean mineral density of the
enamel of each tooth was carried out by first identifying regions
of enamel using ImageJ software (http://imagej.nih.gov/ij/) and
the Trainable Weka Segmentation plugin (http://fiji.sc/
Trainable_Weka_Segmentation). The mean mineral density of
the enamel was determined by measuring the mineral density
of areas identified as enamel on every 10th CT slice taken
through each tooth. Calibrated colour contour maps of mineral
density were also generated using ImageJ.
For SEM, teeth were sectioned with a diamond disk and the
cut surfaces smoothed using fine carborundum paper.
Specimens were etched in 30% phosphoric acid for 20 seconds
followed by thorough rinsing in excess distilled water. Teeth
were dried overnight under vacuum and sputter coated with
gold. Specimens were observed using a Hitachi S-3400N scan-
ning electron microscope (Hitachi, Tokyo, Japan) operated at an
accelerating voltage of 15 kV.
For EDX, elemental analysis was performed on selected re-
gions of the enamel using a detector fitted with an ultrathin
window using Bruker Quantax Espirit software version 1.9.4
(Bruker). A minimum of nine measurements (maximum of
thirty) were obtained for each specified enamel region. The
mean composition of each enamel region was then calculated
using atomic mass percentage measurements.
To investigate the effect of hypochlorite on the enamel, a
fresh enamel surface was exposed by removing the gold coating
with fine carborundum paper and acid etching as described
above. After thorough rinsing in distilled water, the specimen
was immersed in 6% sodium hypochlorite (Sigma, UK) for
10 minutes followed by thorough rinsing in distilled water.
Teeth were dried, sputter coated and imaged and subjected to
EDX elemental analysis as described above.
Supplementary Material
Supplementary Material is available at HMG online.
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